Immune cells from your own tumor could fight advanced melanoma

NCT ID NCT07288203

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests an experimental therapy called lifileucel for people with advanced melanoma that has spread or cannot be removed by surgery and has worsened after standard treatments. About 100 adults will receive their own tumor-fighting immune cells (TILs) grown in a lab. The main goal is to see if the treatment shrinks tumors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRESECTABLE MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

melanoma metastatic melanoma skin neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier de l'Universite de Montreal

    Montral, Quebec, Canada, H2X 0A9, Canada

  • Greenslopes Private Hospital

    Greenslopes, Queensland, 4120, Australia

  • Princess Margaret Cancer Centre

    Toronto, Ontario, Canada, M5G 2M9, Canada

  • Royal Marsden Hospital

    London, SW3 6JJ, United Kingdom

  • Sarah Cannon Research Institute

    Nashville, Tennessee, 37203, United States